Citation Impact
Citing Papers
Colorectal cancer statistics, 2014
2014 Standout
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
Relation between retention factors of immunosuppressive drugs in microemulsion electrokinetic chromatography with biosurfactants and octanol–water partition coefficients
2003
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
2007
Doxorubicin pathways
2010 Standout
Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
2016
R1 Resection by Necessity for Colorectal Liver Metastases
2008
Flavonoids as protectors against doxorubicin cardiotoxicity: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase
2007
Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian)
2010 Standout
Doxorubicin Cardiotoxicity and the Control of Iron Metabolism: Quinone-Dependent and Independent Mechanisms
2004
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Trace determination of anthracyclines in urine: a new high‐performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel
2004
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors
2001
Nasopharyngeal carcinoma
2019 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva
2009
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Anthracyclines: recent developments in their separation and quantitation
2001
MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer
2016
Colorectal cancer
2019 Standout
Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma
2005
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications
2003
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Oxaliplatin: a review of approved uses
2011
Fluorescent Cisplatin Analogues and Cytotoxic Activity
2009
Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer
2007
Analysis of anticancer drugs: A review
2011 Standout
Validation of an LC–MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE)
2009
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
2013 Standout
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
2012
Cisplatin: The first metal based anticancer drug
2019 Standout
Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle‐encapsulated and liposome‐encapsulated doxorubicin formulations
2008
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer
2013
Anticancer steroids: linking natural and semi-synthetic compounds
2012
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Spheroid-based drug screen: considerations and practical approach
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Colorectal cancer
2015
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Development and validation of a high-performance liquid chromatography–tandem mass spectrometric method for quantification of daunorubicin in rat plasma
2006
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Selective determination of doxorubicin and doxorubicinol in rat plasma by HPLC with photosensitization reaction followed by chemiluminescence detection
2008
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Organometallic Anticancer Compounds
2010 Standout
Marine natural products
2015 Standout
Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies
2016
Anticancer and Antimicrobial Metallopharmaceutical Agents Based on Palladium, Gold, and Silver N-Heterocyclic Carbene Complexes
2007
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Synthesis, characterization, plasmid cleavage and cytotoxicity of cancer cells by a copper(ii) complex of anthracenyl-terpyridine
2011
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
2013
Optimization of a liquid chromatographic separation for the simultaneous determination of four anthracyclines and their respective 13‐S‐dihydro metabolites
2008
Combination therapy in combating cancer
2017 Standout
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
2009
Distribution of Zeptomole-Abundant Doxorubicin Metabolites in Subcellular Fractions by Capillary Electrophoresis with Laser-Induced Fluorescence Detection
2002
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
2014
Targeted Cancer Therapy: Giving Histone Deacetylase Inhibitors All They Need To Succeed
2012
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Can metastatic colorectal cancer be cured?
2012
Synthesis of Gold Nanoparticles Using Leaf Extract of Ziziphus zizyphus and their Antimicrobial Activity
2018 Standout
Works of C. Barbara being referenced
Idarubicin and Idarubicinol Effects on Breast Cancer Multicellular Spheroids
2005
MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
2013
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
2015
PHARMACOKINETICS OF AZITHROMYCIN IN LUNG TISSUE, BRONCHIAL WASHING, AND PLASMA IN PATIENTS GIVEN MULTIPLE ORAL DOSES OF 500 AND 1000 MG DAILY
2002
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity
2006
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
2006
An Improved HPLC Method for Therapeutic Drug Monitoring of Daunorubicin, Idarubicin, Doxorubicin, Epirubicin, and Their 13-Dihydro Metabolites in Human Plasma
1999
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007
Analysis of immunosuppressive drugs and their pharmaceuticals by micellar electrokinetic chromatography
2001